| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 94.24× | 94.24× | 100.09× | 101.29× | 83.71× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.18× | 3.21× | 4.43× | 2.96× | 2.90× | ||
| 0.95× | 0.95× | 0.85× | 0.92× | 1.17× | ||
| 74.89× | 74.89× | −1.08× | 2.23× | −2.70× | ||
| 2.39× | 2.39× | −1.94× | 0.59× | −1.17× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 83.71 | 101.29 | 100.09 | 94.24 | 94.24 | |
| Working Capital Turnover | 2.90 | 2.96 | 4.43 | 3.21 | 3.18 | |
| Asset Turnover | 1.17 | 0.92 | 0.85 | 0.95 | 0.95 | |
| Cash Conversion (CFO/Net Income) | -2.70 | 2.23 | -1.08 | 74.89 | 74.89 | |
| CFO/EBITDA | -1.17 | 0.59 | -1.94 | 2.39 | 2.39 |